Invacare ROE 2010-2023 | IVCRQ
Current and historical return on equity (ROE) values for Invacare (IVCRQ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Invacare ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2023-03-31 |
$-0.12B |
$0.05B |
-132.58% |
| 2022-12-31 |
$-0.10B |
$0.08B |
-80.96% |
| 2022-09-30 |
$-0.08B |
$0.08B |
-49.06% |
| 2022-06-30 |
$-0.07B |
$0.15B |
-33.71% |
| 2022-03-31 |
$-0.06B |
$0.19B |
-24.14% |
| 2021-12-31 |
$-0.05B |
$0.22B |
-18.00% |
| 2021-09-30 |
$-0.05B |
$0.24B |
-18.63% |
| 2021-06-30 |
$-0.04B |
$0.28B |
-12.05% |
| 2021-03-31 |
$-0.04B |
$0.28B |
-13.77% |
| 2020-12-31 |
$-0.03B |
$0.33B |
-8.81% |
| 2020-09-30 |
$-0.04B |
$0.33B |
-13.48% |
| 2020-06-30 |
$-0.04B |
$0.30B |
-13.97% |
| 2020-03-31 |
$-0.04B |
$0.31B |
-12.37% |
| 2019-12-31 |
$-0.05B |
$0.31B |
-16.53% |
| 2019-09-30 |
$-0.04B |
$0.32B |
-10.61% |
| 2019-06-30 |
$-0.04B |
$0.33B |
-11.33% |
| 2019-03-31 |
$-0.04B |
$0.35B |
-12.01% |
| 2018-12-31 |
$-0.04B |
$0.36B |
-11.45% |
| 2018-09-30 |
$-0.06B |
$0.37B |
-15.24% |
| 2018-06-30 |
$-0.07B |
$0.39B |
-16.32% |
| 2018-03-31 |
$-0.08B |
$0.42B |
-17.56% |
| 2017-12-31 |
$-0.08B |
$0.42B |
-18.44% |
| 2017-09-30 |
$-0.08B |
$0.44B |
-18.45% |
| 2017-06-30 |
$-0.06B |
$0.43B |
-14.88% |
| 2017-03-31 |
$-0.05B |
$0.41B |
-11.77% |
| 2016-12-31 |
$-0.04B |
$0.42B |
-9.59% |
| 2016-09-30 |
$-0.03B |
$0.47B |
-6.18% |
| 2016-06-30 |
$-0.03B |
$0.47B |
-6.73% |
| 2016-03-31 |
$-0.03B |
$0.48B |
-5.83% |
| 2015-12-31 |
$-0.03B |
$0.46B |
-5.32% |
| 2015-09-30 |
$-0.03B |
$0.49B |
-6.23% |
| 2015-06-30 |
$-0.04B |
$0.49B |
-7.18% |
| 2015-03-31 |
$-0.05B |
$0.51B |
-7.75% |
| 2014-12-31 |
$-0.06B |
$0.57B |
-9.05% |
| 2014-09-30 |
$-0.05B |
$0.61B |
-8.21% |
| 2014-06-30 |
$-0.02B |
$0.64B |
-3.33% |
| 2014-03-31 |
$-0.02B |
$0.66B |
-3.04% |
| 2013-12-31 |
$0.03B |
$0.67B |
5.02% |
| 2013-09-30 |
$0.03B |
$0.67B |
4.96% |
| 2013-06-30 |
$0.02B |
$0.64B |
3.00% |
| 2013-03-31 |
$0.03B |
$0.66B |
4.66% |
| 2012-12-31 |
$0.00B |
$0.62B |
0.32% |
| 2012-09-30 |
$-0.03B |
$0.62B |
-4.20% |
| 2012-06-30 |
$-0.02B |
$0.60B |
-2.50% |
| 2012-03-31 |
$-0.00B |
$0.64B |
-0.45% |
| 2011-12-31 |
$-0.00B |
$0.63B |
-0.59% |
| 2011-09-30 |
$0.04B |
$0.70B |
5.57% |
| 2011-06-30 |
$0.04B |
$0.70B |
6.15% |
| 2011-03-31 |
$0.03B |
$0.68B |
4.55% |
| 2010-12-31 |
$0.03B |
$0.65B |
3.96% |
| 2010-09-30 |
$0.04B |
$0.64B |
5.59% |
| 2010-06-30 |
$0.03B |
$0.59B |
5.08% |
| 2010-03-31 |
$0.04B |
$0.65B |
6.39% |
| 2009-12-31 |
$0.04B |
$0.70B |
6.55% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.000B |
$0.742B |
|
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
|
